First report of treatment of Anaerobiospirillum succiniciproducens bloodstream infection with levofloxacin.
Kelesidis
Theodoros
T
Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave., CHS 37-121, Los Angeles, CA 90095, USA. tkelesidis@mednet.ucla.edu
Dien Bard
Jennifer
J
Humphries
Romney
R
Ward
Kevin
K
Lewinski
Michael A
MA
Uslan
Daniel Z
DZ
D000369:Aged, 80 and over; D044064:Anaerobiospirillum / Q000166:cytology / Q000302:isolation & purification*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000175:diagnosis* / Q000188:drug therapy*; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D004275:DNA, Ribosomal / Q000737:chemistry / Q000235:genetics; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D064704:Levofloxacin; D008297:Male; D008853:Microscopy; D046529:Microscopy, Electron, Transmission; D015242:Ofloxacin / Q000627:therapeutic use*; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D017422:Sequence Analysis, DNA
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D004275:DNA, Ribosomal; D012336:RNA, Ribosomal, 16S; D064704:Levofloxacin; D015242:Ofloxacin